Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Life science company Inficure Bio has been awarded millions by Vinnova to support the company's development of a model that will help create new treatments for fibrosis.
April 2, 2019 – InDex Pharmaceuticals Holding AB (publ) today publishes the Annual Report for 2018, which is earlier than indicated in the financial calendar. The Annual Report (in the Swedish language) is attached as a PDF and is available on the company’s website, www.indexpharma.com.
MVA-member, Ascelia Pharma, publishes prospectus in connection with Initial Public Offering on Nasdaq Stockholm
Continued focus on the patient recruitment for the CONDUCT study
Operating profit increased by 6% measured in local currencies when adjusted for the cost of severance and the priority review voucher for oral semaglutide
In 2018 SmiLe met its annual goal of finding about ten new life science startup companies with a strong team, a high level of innovation and strong international market potential. SmiLe has thereby helped a total of 70 companies to develop their products for better health, including the current 22 member companies. Together, they have attracted a record amount of SEK 728 million in venture capital, 18 percent more than the previous year’s high figure.